These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23299499)

  • 1. A window into immunoglobulin quantitation and plasma cell disease: antigen epitopes defined by the junction of immunoglobulin heavy and light chains.
    Katzmann JA; Rajkumar SV
    Leukemia; 2013 Jan; 27(1):1-2. PubMed ID: 23299499
    [No Abstract]   [Full Text] [Related]  

  • 2. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
    Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
    Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 71-year-old woman with multiple myeloma status after stem cell transplantation.
    Donato LJ; Zeldenrust SR; Murray DL; Katzmann JA
    Clin Chem; 2011 Dec; 57(12):1645-8. PubMed ID: 22125317
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used.
    Bossuyt X; Delforge M; Reynders M; Dillaerts D; Sprangers B; Fostier K; Poesen K; Vercammen M
    Leukemia; 2018 Aug; 32(8):1815-1818. PubMed ID: 29674643
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunochemical evaluation of monoclonal gammopathies: heavy chain to light chain ratio is of little practical value for detecting IgD myelomas and free light chains.
    Bianchi P; MacNamara E; Bergami MR; Gasparro C; Jones R; Whicher JT; Bienvenu J; Aguzzi F
    Clin Chem; 1992 Feb; 38(2):317-9. PubMed ID: 1541025
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia.
    Qiu X; Sun X; He Z; Huang J; Hu F; Chen L; Lin P; You MJ; Medeiros LJ; Yin CC
    Leukemia; 2013 Jan; 27(1):92-9. PubMed ID: 22772058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
    Dispenzieri A; Katzmann JA; Kyle RA; Larson DR; Melton LJ; Colby CL; Therneau TM; Clark R; Kumar SK; Bradwell A; Fonseca R; Jelinek DF; Rajkumar SV
    Lancet; 2010 May; 375(9727):1721-8. PubMed ID: 20472173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy.
    Evliyaoglu O; van Helden J; Jaruschewski S; Imöhl M; Weiskirchen R
    Clin Biochem; 2019 Dec; 74():42-46. PubMed ID: 31526775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
    Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma.
    Ludwig H; Milosavljevic D; Berlanga O; Zojer N; Hübl W; Fritz V; Harding S
    Am J Hematol; 2016 Mar; 91(3):295-301. PubMed ID: 26662888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays.
    Kaleta E; Kyle R; Clark R; Katzmann J
    Clin Chem Lab Med; 2014 May; 52(5):665-9. PubMed ID: 24327529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains.
    Gu HJ; Cho SY; Lee J; Sung JY; Park TS
    Clin Chem Lab Med; 2017 Jan; 55(1):e21-e24. PubMed ID: 27442368
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
    Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
    Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free light chains and heavy/light chains in monitoring POEMS patients.
    Altinier S; Proko K; Zaninotto M; Ciubotaru D; Seguso M; Varagnolo M; Lessi F; Briani C; Adami F; Plebani M
    Clin Chem Lab Med; 2016 Jun; 54(6):1065-71. PubMed ID: 27071150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update in multiple myeloma: international criteria for treatment response and renal complications].
    Decaux O; Karras A
    Rev Med Interne; 2009 Dec; 30(12):1080-3. PubMed ID: 19833418
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
    Yang JJ; Zhang GS; Chen XR
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.